Deargen
Signal active
Organization
Contact Information
Overview
Deargen provides AI-based genome analysis service.
About
Industries
Biotechnology, Artificial Intelligence (AI), Machine Learning
Founded
2016
Employees
51-100
Headquarters locations
Asia
Social
N/A
Profile Resume
Deargen headquartered in Asia, operates in the Biotechnology, Artificial Intelligence (AI), Machine Learning sector. The company focuses on Biotechnology and has secured $692.3M in funding across 36 round(s). With a team of 51-100 employees, Deargen is actively contributing to advancements in Biotechnology. Their latest funding round, Non Equity Assistance - Deargen, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$19.2M
Details
2
Deargen has raised a total of $19.2M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 16.6M | ||
| 2020 | Seed | 2.6M |
Investors
Deargen is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Deargen | - | FUNDING ROUND - Deargen | 2.6M |
| Hana Ventures | - | FUNDING ROUND - Hana Ventures | 2.6M |
| Deargen | - | FUNDING ROUND - Deargen | undefined |
| TIPS Program | - | FUNDING ROUND - TIPS Program | undefined |
Recent Activity
There is no recent news or activity for this profile.